Condition
HER2 Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HER2 Mutation clinical trials that are recruiting, at sites in 20 countries (most in China (2), France (2), Italy (2)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 20Countries
All recruiting trials (2)
-
Treatment for solid tumors with HER2 mutations using BAY2927088 tablets
This study is testing if BAY2927088 tablets can help people with advanced solid tumors that have HER2 gene mutations feel better and manage their cancer.
-
First-in-human test of BAY2927088 for advanced NSCLC with EGFR and/or HER2 mutations
This study tests BAY2927088 to see if it is safe and tolerable in people with advanced NSCLC that carry EGFR or HER2 mutations.
Related topics
Quick answers
How many HER2 Mutation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in China (2 trials), France (2 trials), Italy (2 trials), Japan (2 trials), South Korea (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.